Registry for Acute Decompensated Heart Failure Patients Admitted to the ER

This study has been completed.
Sponsor:
Information provided by:
Scios, Inc.
ClinicalTrials.gov Identifier:
NCT00364325
First received: August 11, 2006
Last updated: April 26, 2010
Last verified: April 2010

August 11, 2006
April 26, 2010
July 2004
Not Provided
The registry will capture information about the medical care that the patient has received including hospital/ emergency department course, major procedures, medication received, emergency room disposition and in hospital death [ Time Frame: Data will be collected, beginning with care in the Emergency Department and ending with the patient's Discharge from the Emergency Department or hospital discharge, transfer to another hospital, or in-hospital death. ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00364325 on ClinicalTrials.gov Archive Site
Baseline demographic information (age,sex, gender,race), initial evaluation, laboratory results and medical history. [ Time Frame: From admission to the emergency depatment until discharge ] [ Designated as safety issue: No ]
Not Provided
Not Provided
Not Provided
 
Registry for Acute Decompensated Heart Failure Patients Admitted to the ER
Acute Decompensate Heart Failure National Registry ( ADHERE) Emergency Module (EM)

The purpose of this study is to collect data on the medical management of patients presenting to the Emergency Department who are treated for Acute Decompensated Heart Failure (ADHF) in a hospital setting that has incorporated a disease management program for heart failure.

This is an Observational (individuals are observed or certain outcomes are measured. no attempt is made to affect the outcome), multi-center registry study of patients presenting to the Emergency Department (ED) for treatment of known or suspected Acute Decompensated Heart Failure (ADHF). Data will be collected on the medical management of patients presenting to the ED who are treated for ADHF in a hospital setting incorporating a disease management program for heart failure. The study will evaluate change in clinical management and outcomes of ADHF patients treated in the ED after ED implementation of three or more components of a disease management program for heart failure. The results are intended to assist hospitals in evaluating and improving quality of care for patients with ADHF by tracking quality indicators and providing site-specific benchmark reports and national benchmark reports. This registry considers patients treated with any therapy for ADHF

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

The study population consists of all consecutive adults patients seen in the Emergency department of an acute care hospital and treated actively for Acute Decompensated Heart Failure (ADHF) where the condition is defined clinically as new onset of Heart Failure with decompensation or chronic heart failure with decompensation. Patient eligibility is based upon the presence of a hospital discharge and/or Emergency department diagnosis of ADHF and is not tied to the use of any specific therapeutic agent or regimen.

  • Heart Failure, Congestive
  • Heart Decompensation
Other: Acute Decompensated Heart Failure
Standard of Care
001
Intervention: Other: Acute Decompensated Heart Failure
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
18920
March 2006
Not Provided

Inclusion Criteria:

  • Age greater than or equal to 18 years at the time of ED treatment
  • Received or is eligible to receive a principal ED and/or hospital discharge diagnosis of ADHF
  • ADHF is present as determined clinically by the patient care team and as documented in the DRG (Diagnosis-related Group) or APC (Ambulatory Payment Classifications) codes, and ADHF is the focus of treatment
  • If required by site IRB/IEC patient (or legally acceptable representative) must be able to give informed consent for participation

Exclusion Criteria:

  • ADHF is present as a co-morbid condition, but is not a principal focus of diagnosis or treatment during this ED or hospital episode
  • Patient was not treated in ED during this episode of care
  • Participation in any clinical trial that precludes use of a Disease Management Program (specific component of the disease are managed in an integrated manner by a team of physicians, pharmacists, nurses and communication experts)
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00364325
CR005215
Not Provided
Sr. Director, Clinical Team Leader, Scios
Scios, Inc.
Not Provided
Study Director: Scios, Inc. Clinical Trial Scios, Inc.
Scios, Inc.
April 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP